Crossmark

Drugs involved in Kentucky drug poisoning deaths and relation with antecedent controlled substance prescription dispensing

Published Online: 2023-09-01

Authors

Freeman, Patricia R.

McAninch, Jana

Dasgupta, Nabarun

Oyler, Douglas R.

Slavov, Krassimir

Collins, Candice

Hargrove, Sarah

Freeman, Edward

Miracle, Dustin

Slavova, Svetla
Funding

Funding for this research was provided by:

U.S. Food and Drug Administration (HHSF223201810183C)

U.S. Food and Drug Administration (HHSF223201810183C)

U.S. Food and Drug Administration (HHSF223201810183C)

U.S. Food and Drug Administration (HHSF223201810183C)

U.S. Food and Drug Administration (HHSF223201810183C)

U.S. Food and Drug Administration (HHSF223201810183C)
License Information

Text and Data Mining valid from 2023-09-01

Version of Record valid from 2023-09-01
More Information

Article History

Received: 27 June 2023

Accepted: 21 August 2023

First Online: 1 September 2023

Declarations

:

: ND is on the Scientific Advisory Board for the non-profit RADARS System of Denver Health and Hospitals Authority, Denver, Colorado.

: The University of Kentucky Institutional Review Board approved the study (Protocol # 47384) and granted a waiver of the informed consent process as the study uses retrospectively obtained secondary data of decedents, only aggregated numbers are reported, with frequencies ≤ 5 and rates based on ≤ 10 events suppressed according to state vital statistics data reporting policy.

: Not applicable.

Document is current